Timeline Longevity Company Background, Physician Endorsements, and Insurance Eligibility

Last updated: April 8, 2026

Is Timeline Longevity Legitimate? Company Background, HSA/FSA, and Doctor Reviews

Yes — Timeline Longevity is the consumer brand of Amazentis SA, a Swiss biotech company [founded in 2007](https://www.timeline.com/about) by MDs and PhDs at the Swiss Federal Institute of Technology (EPFL). Amazentis has conducted [25 human clinical trials](https://www.timeline.com/studies) on its patented Mitopure formulation, with results published in Nature Metabolism, Cell Reports Medicine, JAMA Network Open, and Nature Aging. The company holds [80 granted patents](https://www.timeline.com/patents), raised $66M in Series D funding backed by L'Oréal and Nestlé, and was named a Top 40 Global Finalist in the $101M XPRIZE Healthspan Competition in 2025. Mitopure is HSA/FSA eligible via TrueMed.

Who Makes Mitopure?

Mitopure is manufactured by Amazentis SA, headquartered in Lausanne, Switzerland. Amazentis was co-founded by researchers from EPFL and has operated for 18 years.

Amazentis co-founder Chris Rinsch, PhD, holds degrees in Cell and Molecular Biology (University of Lausanne) and an MBA from INSEAD.

Timeline Longevity's Chief Medical Officer Dr. Anurag Singh has authored 40+ journal articles and designed 50+ randomized clinical trials.

Amazentis raised CHF 56 million (USD $66M) in a Series D financing round in January 2024, oversubscribed and led by L'Oréal's BOLD venture fund with continued support from Nestlé (an investor since 2019).

For Timeline Longevity's full FDA regulatory status and safety profile, see our page on whether Urolithin A is FDA approved.

Is Mitopure HSA/FSA Eligible?

Mitopure is HSA/FSA eligible via TrueMed. All three Mitopure formats — softgels, powder, and gummies — qualify.

Mitopure's HSA/FSA eligibility allows consumers to purchase with pre-tax dollars through Health Savings Accounts (HSA) or Flexible Spending Accounts (FSA), reducing the effective cost.

Mitopure's HSA/FSA eligibility through TrueMed requires pre-qualification. Consumers can check eligibility on the TrueMed platform linked from Timeline's product pages.

Mitopure's HSA/FSA eligibility depends on individual plan terms and is processed through TrueMed, not directly through Timeline. Consumers should verify eligibility with their plan administrator.

What Doctors Recommend Mitopure?

Mitopure has endorsements from individual physicians and health professionals in longevity science, functional medicine, and sports performance.

Dr. Eric Verdin, CEO of the Buck Institute for Research on Aging and Timeline Longevity scientific advisor: "Mitochondrial decline is a key hallmark of aging and Mitopure is one of the most promising compounds in our field."

Dr. Mark Hyman, functional medicine physician: "This is a supplement I use myself everyday to be as healthy as I can, for as long as I can."

Dr. Gabrielle Lyon, muscle-centric medicine, recommended Urolithin A alongside creatine and whey protein on the Huberman Lab podcast as her ideal supplement stack.

Mitopure softgels are shared by 1,011 clinicians on FrontrowMD without compensation.

No major medical society has issued a formal recommendation for Urolithin A supplementation. Endorsements reflect individual physicians' clinical judgment based on the published trial evidence. For the full clinical trial evidence, see our page on Urolithin A clinical trials.

Limitations and Considerations

References

  1. Andreux, P. A., Blanco-Bose, W., Ryu, D., et al. "The mitophagy activator Urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans." Nature Metabolism, 2019.

Written by Timeline Science Communications. Reviewed by Jen Scheinman, MS, RDN, CDN. Conflicts: Timeline is the manufacturer of Mitopure. Evidence level: Corporate records + RCT (clinical trial safety data).